Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Abbott Laboratories (NYSE:ABT)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Abbott Laboratories for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Adjustments to Financial Statements

Advanced level

Adjustments to Current Assets

Abbott Laboratories, adjusted current assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Current assets
Adjustments
Add: Allowances for doubtful accounts and product returns
After Adjustment
Adjusted current assets

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

Adjustments to Total Assets

Abbott Laboratories, adjusted total assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total assets
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Add: Allowances for doubtful accounts and product returns
After Adjustment
Adjusted total assets

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

Adjustments to Total Liabilities

Abbott Laboratories, adjusted total liabilities

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total liabilities
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1
Less: Deferred income taxes2
Less: Restructuring Plans, accrued balance
After Adjustment
Adjusted total liabilities

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred income taxes. See details »

Adjustments to Stockholders’ Equity

Abbott Laboratories, adjusted total Abbott shareholders’ investment

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total Abbott shareholders’ investment
Adjustments
Less: Net deferred tax assets (liabilities)1
Add: Allowances for doubtful accounts and product returns
Add: Restructuring Plans, accrued balance
Add: Noncontrolling interests in subsidiaries
After Adjustment
Adjusted total shareholders’ investment

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

1 Net deferred tax assets (liabilities). See details »

Adjustments to Capitalization Table

Abbott Laboratories, adjusted capitalization table

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Short-term borrowings
Current portion of long-term debt
Long-term debt, excluding current portion
Total reported debt
Total Abbott shareholders’ investment
Total reported capital
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1
Add: Current operating lease liabilities (included in Other accrued liabilities)2
Add: Long-term operating lease liabilities3
Adjusted total debt
Adjustments to Equity
Less: Net deferred tax assets (liabilities)4
Add: Allowances for doubtful accounts and product returns
Add: Restructuring Plans, accrued balance
Add: Noncontrolling interests in subsidiaries
Adjusted total shareholders’ investment
After Adjustment
Adjusted total capital

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Current operating lease liabilities (included in Other accrued liabilities). See details »

3 Long-term operating lease liabilities. See details »

4 Net deferred tax assets (liabilities). See details »

Adjustments to Reported Income

Abbott Laboratories, adjusted net earnings

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Net earnings
Adjustments
Add: Deferred income tax expense (benefit)1
Add: Increase (decrease) in allowances for doubtful accounts and product returns
Add: Increase (decrease) in restructuring Plans, accrued balance
Less: Net earnings from discontinued operations, net of taxes
Add: Other comprehensive income (loss)
After Adjustment
Adjusted net earnings

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

1 Deferred income tax expense (benefit). See details »